Michael Ameismeier

PhD student at the Gene Center Munich | Structural Biologist

[Beckmann Lab @BeckmannLab]

Excited to see our #ABCE1 #initiation story finally published in @embojournal! We added additional data to our high resolution PIC inventory, revealing that eIF3j binds as a dimer blocking the mRNA entry channel and interacting with ABCE1.
https://t.co/piU8R6p6VT

[Michael Ameismeier @ameismeier]

... They have been incredibly open with their results and readily shared their insights and data with us. Overall a wonderful experience of collaboration!

[Michael Ameismeier @ameismeier]

Glad to see this finally out. This nicely wraps up my PhD. Massive thanks to Roland and all my colleagues in the @BeckmannLab for those amazing four years!

[Beckmann Lab @BeckmannLab]

We're excited to share with you our latest story on 40S biogenesis. See how the final 18S rRNA processing step is coordinated in humans. Congratulations to freshly-minted Dr. @ameismeier and shout-out to the Kutay Lab for the amazing collaboration! https://t.co/k2XCjv1ZmT

[Michael Ameismeier @ameismeier]

Also, this story would not have been possible without the experimental validation of EIF1AD and LRRC47 by Jasmin and Ivo from the Kutay Lab. We contacted them after they mentioned these factors in their 2020 on paper on USP16. (https://t.co/8PH0yDL2CR) ...

[The Nobel Prize @NobelPrize]

BREAKING NEWS:
The 2020 #NobelPrize in Chemistry has been awarded to Emmanuelle Charpentier and Jennifer A. Doudna “for the development of a method for genome editing.”

[Michael Ameismeier @ameismeier]

@IsraelF96135088 @R_Buschauer @CrollTristan @BeckmannLab @jhdcate Calling K3 old technology...

*cries with a Falcon II*

[Science Magazine @ScienceMagazine]

A detailed study of a #SARSCoV2 protein, Nsp1, with a role in weakening the host anti-viral immune response shows that it interferes with production of immune-related proteins in the host. Targeting this interaction may be a therapeutic strategy. https://t.co/HYojsv19X0

[Gene Center Munich @GeneCenter_LMU]

Congrats to the Beckmann lab: in cooperation with the Sparrer lab in Ulm they published exciting research results #coronavirus research #COVID19: Nsp1 of #SARSCoV2 hijackes the #ribosome to shut down #translation and evade the innate immune response. 👏👏https://t.co/NrqnQS9mfe

[Beckmann Lab @BeckmannLab]

Dr. Kater in collaboration with the Hurt lab on how to build the 60S subunit

[Christian Drosten @c_drosten]

Der Bild-Reporter hat unseren englischsprachigen Mathematiker am Telefon in die Irre geführt. Er bekam die Auskunft, dass wir grade an einem Update der Studie arbeiten, das aber das Ergebnis nicht ändert. Daraus wird dann eine interne Kritik gemacht https://t.co/w3NjKfo0Ib

[QMB Munich @MunichQbm]

QBM is open for applications from June 1st to August 31st
Apply now: https://t.co/af3syVPeiD

[Michael Ameismeier @ameismeier]

@SetyantoWahyudi @BeckmannLab @biorxivpreprint We're still finalising the models but should be depositing them soon

[Michael Ameismeier @ameismeier]

@SetyantoWahyudi @BeckmannLab @biorxivpreprint We have built the C-terminal part of Nsp1 from scratch using the cryo-EM volume and Nsp1 amino acid sequence

[Michael Ameismeier @ameismeier]

What an extraordinary occasion to join the Twittersphere :)

[Beckmann Lab @BeckmannLab]

Nsp1 of #SARSCoV2 hijackes the #ribosome to shut down #translation and evade the innate immune response. Excited to share our latest #coronavirus research on @biorxivpreprint  #COVID19
https://t.co/l660ns3Bqt